Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
40 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
MYELOMA PATIENTS EUROPE from Elsene, company number BE0842182407, closed financial year 2025 with a result of € 154,630 after tax. For that financial year MYELOMA PATIENTS EUROPE recorded a gross margin of € 975,752 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 49,725 to € 154,630. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 8, 2026.
€ 1.1 million
▲ 17% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 154,630
▲ 211% vs 2024
Profit after tax over the fiscal year.
€ 1 million
▼ 20% vs 2024
Cash and bank balances on the last day of the fiscal year.
People and assets in 2025
13.4
▲ 1.8 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 785,321
▲ 14% vs 2024
€ 58,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 32,912
▲ 25% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 22,644
▲ 19% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 561,695 | € 709,128 | € 769,173 | € 975,752 | ▲ 27% |
| Profit after taxes | € -46,566 | € 33,450 | € 49,725 | € 154,630 | ▲ 211% |
| Equity | € 838,963 | € 872,413 | € 922,137 | € 1,076,767 | ▲ 17% |
| Total debts | € 33,151 | € 546,239 | € 823,974 | € 651,965 | ▼ 21% |
| Cash | € 809,055 | € 1,350,998 | € 1,249,026 | € 1,004,937 | ▼ 20% |
| Retained profit | € 838,963 | € 872,413 | € 922,137 | € 1,076,767 | ▲ 17% |
| Balance sheet total | € 872,114 | € 1,418,652 | € 1,746,111 | € 1,728,732 | ▼ 1% |
| Employees (FTE) | 10.5 | 11 | 11.6 | 13.4 | ▲ 1.8 |
Key figures of MYELOMA PATIENTS EUROPE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to MYELOMA PATIENTS EUROPE?
What happened at MYELOMA PATIENTS EUROPE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 154,630 (▲ 211% vs 2024). Source: NBB ↗
- Madame Lidija Pecova became a director. NBB
- Madame Liselott Eriksson stepped down as director. NBB
- Madame Kristina Modic became a director. NBB
- Monsieur Vincent Pierre Claus became a director. NBB
- Monsieur Reidar Frode Nordby became a director. NBB
- Madame Snezana Doder became a director. NBB
- Madame Diane Eugene Loening-Martens became a director. NBB
In short
From € 46,566 loss in 2022 to € 154,630 profit in 2025.
Best year ever: 2025, with € 154,630 profit.
On average € 72,800 of value added per employee in 2025.
A new publication or filing at MYELOMA PATIENTS EUROPE? We notify you, reason included.
Follow MYELOMA PATIENTS EUROPEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind MYELOMA PATIENTS EUROPE are Madame Diane Eugene Loening-Martens, Monsieur Reidar Frode Nordby, Madame Snezana Doder, Madame Kristina Modic, Monsieur Vincent Pierre Claus and Madame Barbara Jadwiga Leonardi .
Directors
According to the 2025 annual accounts
Madame Diane Eugene Loening-Martens
Vice-chairman of the board
since 2022
Monsieur Reidar Frode Nordby
Director
since 2023
Madame Snezana Doder
Director
since 2022
Madame Kristina Modic
Director
since 2024
Monsieur Vincent Pierre Claus
Director
since 2024
Madame Barbara Jadwiga Leonardi
Chairman of the board
since 2022
Madame Lidija Pecova
Director
since 2025
Monsieur Zvi Zilberman
Director
since 2022
Madame Liselott Eriksson
Director
since 2020 · until 2025
Establishments
Establishment units
Physical locations of this company
Louizalaan 143 box 4
1050 Elsene
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 40 companies are registered at this address.
All companies at this address →Socobom
€ 123,176 gross margin · 2025
Comptoir Bogaerts
GEVELE
€ 3.7 million revenue · 2025
ELARMEC
€ 392,913 gross margin · 2025
AUSI A ET P
€ 6,839 gross margin · 2025
+35 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Certifications & Partners
Hosting & Email
Email provider
Microsoft 365
Hosting
AS-HOSTINGER, CY
Domain
Domain
mpeurope.org
Registered
2013-03-11
Registrar
Gandi SAS
Expires
2027-03-11
Website info
Features
Security
Network
Details
- Company number
- 0842.182.407
- VAT number
- BE 0842.182.407
- Registered office
- Louizalaan 143 bus 4, 1050 Elsene
- Names & denominations
- MYELOMA PATIENTS EUROPE
- Enterprise type
- Rechtspersoon
- Legal form
- International non-profit association
- Legal situation
- Normale toestand
- Start date
- 28 December 2011
- Peppol
- Active · Active since 12 Jan 2026
- Contact
- mpeurope.org
- Activities · NACE
Overige verenigingen, neg
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering